跳至主要内容
临床试验/NCT04604249
NCT04604249Unknown不适用

Prevalence of COVID-19 and Risk Factors Associated With Seroconversion in La Rinconada, the Highest City of the World - 5,100 m

Centre d'Expertise sur l'Altitude EXALT1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2020年10月26日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
200
试验地点
1
主要终点
1. Prevalence of seroconversion for SARS-CoV-2.

研究概览

简要总结

Since the beginning of 2020, SARS-CoV-2 outbreak spread over the world, conducting in a pandemic state declared by the world health organization in March 2020. Conflicting data have been yet published regarding to the incidence rate of COVID-19 infection in altitude. Mainly based on analysis from national Peru database, some authors argued that COVID-19 disease, as well as case fatality rate was less frequent in altitude. However, epidemiological data are lacking regarding to the prevalence of COVID-19 in altitude, and more specially in high altitude.

Aim of this cross-sectional study is to assess the prevalence of seroconversion for the SARS-CoV-2 in the population of La Rinconada, a mining town at 5,100 m, the highest city in the world.

研究设计

研究类型
Observational
观察模型
Ecologic Or Community
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age > 18 years.

排除标准

  • Age < 18 years.
  • Inability to give informed consent.

结局指标

主要结局

1. Prevalence of seroconversion for SARS-CoV-2.

时间窗: Through study completion, an average of 1 week

次要结局

  • 2. Occupational and environmental exposures associated with SARS-CoV-2 seroconversion.(Through study completion, an average of 1 week)

研究者

发起方
Centre d'Expertise sur l'Altitude EXALT
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Prevalence of COVID-19 in High Altitude : Insights... | 临床试验